Optometrists in Otsego, MN Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Dr. Kelsey Marie Manescalco, OD Optometrist - Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 15704 90th St Ne # 100, Otsego, MN 55330 Phone: 763-241-1090 |
Dr. Amber Reinhart Scharnweber Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9125 Quaday Ave Ne, Suite #104, Otsego, MN 55330 Phone: 763-241-1090 |
 Advancements In Vision, Pa Optometrist - Vision Therapy Medicare: Not Enrolled in Medicare Practice Location: 9125 Quaday Ave Ne, Suite 104, Otsego, MN 55330 Phone: 763-241-1090 |
Dr. Pamela J Wendlandt, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 15704 90th St Ne, Suite 100, Otsego, MN 55330 Phone: 763-241-1090 Fax: 763-241-1091 |
 Dr. Zachary Unrau, OD Optometrist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15704 90th St Ne Ste 100, Otsego, MN 55330 Phone: 763-241-1090 |
Bright Eyes Vision Clinic, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 9125 Quaday Ave Ne, Suite 104, Otsego, MN 55330 Phone: 763-241-1090 |
Inna Timshina Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15704 90th St Ne, #100, Otsego, MN 55330 Phone: 763-241-1090 |
Dr. Jill Schultz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 15704 90th St Ne, Suite 100, Otsego, MN 55330 Phone: 763-241-1090 Fax: 763-241-1091 |
News Archive
Global Med to market the Spanish verIDhemos transfusion safety system
Global Med Technologies(R), Inc. an international healthcare information technology company, today announced that it has signed a binding letter of intent with verIDentia SL of Macanet De La Selva, Girona, Spain for its verIDhemos transfusion safety system. Terms of the agreement were not disclosed.
Loop-mediated Isothermal Amplification test for human African trypanosomiasis
The Geneva-based not-for-profit foundation FIND and Japanese diagnostics company Eiken announced today that a next-generation molecular test designed specifically for sleeping sickness - a deadly parasitic disease also known as human African trypanosomiasis (HAT) - is ready to enter accelerated field trials in sites across the Democratic Republic of Congo and Uganda.
Cangene announces development of Immune Globulin Intravenous product
Cangene Corporation today announces that it is developing an Immune Globulin Intravenous product, commonly known as IGIV. IGIV is a widely used anti-infective with a variety of indications including treating primary immune deficiency, immune thrombocytopenic purpura and other inflammatory and autoimmune diseases.
New study: Egg donors may be paid too much
"Women who donate eggs for use with in-vitro techniques aren't supposed to be compensated more than $10,000 .... according to guidelines from the American Society of Reproductive Medicine," The Wall Street Journal reports.
U.S. Senators introduce Pulmonary Fibrosis Research Enhancement Act
The Coalition for Pulmonary Fibrosis (CPF) announced today the Pulmonary Fibrosis Research Enhancement Act has been introduced in the Senate by Senators Chris Coons and Mike Crapo in the U.S. House of Representatives by Rep. Erik Paulsen and Rep. Tammy Baldwin.
› Verified 4 days ago
Occupational Therapists
Chiropractors
Optometrists
Speech-Language Pathologists
Physical Therapists